You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 10,588,988


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,588,988
Title:Methods and devices for preparation of ultrasound contrast agents
Abstract: Provided herein are methods and devices for identifying and/or distinguishing UCA formulations and specifically activating such formulations to produce UCA suitable for in vivo use.
Inventor(s): Robinson; Simon P. (Stow, MA), Walker; Carol (Billerica, MA), Onthank; David C. (Groton, MA), Lazewatsky; Joel (Auburndale, MA), Nguyen; Nhung Tuyet (Westford, MA)
Assignee: Lantheus Medical Imaging, Inc. (North Billerica, MA)
Application Number:16/559,528
Patent Claim Types:
see list of patent claims
Use; Formulation; Device;

Drugs Protected by US Patent 10,588,988

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 RX Yes Yes ⤷  Sign Up ⤷  Sign Up METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING ⤷  Sign Up
Lantheus Medcl DEFINITY RT perflutren INJECTABLE;INTRAVENOUS 021064-002 Nov 17, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,588,988

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2017260532 ⤷  Sign Up
Brazil 112018072342 ⤷  Sign Up
Canada 3022698 ⤷  Sign Up
China 109641068 ⤷  Sign Up
China 115531560 ⤷  Sign Up
Eurasian Patent Organization 201892520 ⤷  Sign Up
European Patent Office 3452108 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.